Trifluoperazine, marketed under the brand name Stelazine among others, is a typical antipsychotic primarily used to treat schizophrenia. It may also be used short term in those with generalized anxiety disorder but is less preferred to benzodiazepines. It is of the phenothiazine chemical class. It was approved for medical use in the United States in 1959.
|
Read full article at Wikipedia
|
InChI=1S/C24H31N3O2S/c1- 2- 22(29) 19- 8- 9- 24- 21(18- 19) 27(20- 6- 3- 4- 7- 23(20) 30- 24) 11- 5- 10- 25- 12- 14- 26(15- 13- 25) 16- 17- 28/h3- 4,6- 9,18,28H,2,5,10- 17H2,1H3 |
XZSMZRXAEFNJCU-UHFFFAOYSA-N |
CCC(=O)C1=CC2=C(SC3=C(C=CC=C3)N2CCCN2CCN(CCO)CC2)C=C1 |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
dopaminergic antagonist
A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
|
|
dopaminergic antagonist
A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
antiemetic
A drug used to prevent nausea or vomiting. An antiemetic may act by a wide range of mechanisms: it might affect the medullary control centres (the vomiting centre and the chemoreceptive trigger zone) or affect the peripheral receptors.
phenothiazine antipsychotic drug
|
|
View more via ChEBI Ontology
1-(10-{3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl}-10H-phenothiazin-2-yl)propan-1-one
|
carfenazina
|
WHO MedNet
|
carfénazine
|
WHO MedNet
|
carfenazine
|
WHO MedNet
|
carfenazinum
|
WHO MedNet
|
1-(10-(3-(4-(2-hydroxyethyl)-1-piperazinyl)propyl)phenothiazin-2-yl)-1-propanone
|
ChemIDplus
|
carphenazine
|
ChemIDplus
|
2622-30-2
|
CAS Registry Number
|
ChemIDplus
|
2622-30-2
|
CAS Registry Number
|
NIST Chemistry WebBook
|
901640
|
Beilstein Registry Number
|
Beilstein
|
|